Author (year) | Design | Population | Number of subjects | Mean age | Male | Mean BMI | Dose | Follow-up durations | Adiponectin measurement |
---|---|---|---|---|---|---|---|---|---|
 |  |  |  | years | % | Kg/m2 | mg/d | weeks |  |
Shetty 2004 | R, DB, PC | DM patients or subjects at risk for T2DM | 77 | 51.1 | 55.8 | 29.2 | 20 | 12 | RIA |
Koh 2005 | R, DB, PC, CO | Combined HL patients | 56 | 56.0 | 41.1 | 25.5 | 10 | 8 | ELISA |
Chan 2008 | R | Post-PCI CAD patients | 60 | 65.0 | 71.7 | 25.5 | 10 | 24 | RIA |
von Eynatten 2009 | R, SB, PC | T2DM patients | 75 | 60.9 | 69.3 | 28.2 | 40 | 8 | ELISA |
van Hoek 2009–10 mga | R, DB, PC | T2DM patients | 109 | 59.3 | 55.4 | 30.7 | 10 | 30 | ELISA |
van Hoek 2009–80 mga | R, DB, PC | T2DM patients | 108 | 59.6 | 50.7 | 30.9 | 80 | 30 | ELISA |
Carnevale 2010 | R, SB | HC patients | 36 | 55.2 | 47.2 | 25.2 | 10 | 4 | ELISA |
Koh 2010–10 mgb | R, SB, PC | HC patients | 53 | 55.6 | 51.2 | 24.8 | 10 | 8 | ELISA |
Koh 2010–20 mgb | R, SB, PC | HC patients | 55 | 57.2 | 50.0 | 24.9 | 20 | 8 | ELISA |
Koh 2010–40 mgb | R, SB, PC | HC patients | 54 | 58.0 | 51.7 | 25.0 | 40 | 8 | ELISA |
Koh 2010–80 mgb | R, SB, PC | HC patients | 51 | 56.4 | 51.2 | 24.9 | 80 | 8 | ELISA |
Koh 2011 | R, SB, PC, CO | HTN patients | 42 | 53.0 | 52.4 | 25.5 | 20 | 8 | RIA |
El-Barbary 2011 | R, OL | RA patients | 30 | 54.2 | 16.7 | 25.7 | 40 | 24 | ELISA |
Buldak 2012 | R, SB | HL patients with IFG | 37 | 50.9 | 54.1 | 28.1 | 10 | 12 | ELISA |